Phase II Cardiac Rehabilitation Using Treadmill and Cycle Ergometer: A Case Report

Authors

  • Fauzia Alya Putri Professional Physiotherapy Program, Faculty of Health Sciences, Universitas Muhammadiyah Surakarta, Central Java, Indonesia Author
  • Farid Rahman Faculty of Health Sciences, Universitas Muhammadiyah Surakarta, Central Java, Indonesia Author
  • Kadek Agustini Aryani Integrated Cardiac Care Department, Prof. dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali, Indonesia Author

DOI:

https://doi.org/10.24843/

Keywords:

Heart Failure, Cardiac Rehabilitation, Treadmill Exercise, Cycling, Aerobic Capacity

Abstract

Background: Congestive heart failure (CHF) is characterized by impaired cardiac output, leading to reduced aerobic capacity and functional limitation. Phase II cardiac rehabilitation is recommended to improve cardiopulmonary function after coronary artery bypass grafting (CABG).
Objective: To evaluate the effects of a Phase II cardiac rehabilitation program using treadmill and cycle ergometer exercise on aerobic capacity in a patient with CHF due to three-vessel coronary artery disease (CAD) after CABG.
Methods: This case report involved a 52-year-old male with CHF et causa CAD three-vessel disease following CABG. The patient participated in a supervised Phase II cardiac rehabilitation program consisting of treadmill walking and cycle ergometer training, performed 3–5 sessions per week over five sessions, with each session lasting 20–60 minutes. Aerobic capacity was assessed using the 6-Minute Walk Test (6MWT), metabolic equivalents (METs), Borg Rating of Perceived Exertion, and vital signs measured before and after the intervention.
Results: Aerobic capacity improved, with METs increasing from 4.13 to 4.90 (+18.6%) and 6MWT distance increasing from 350 m to 441 m (+26.0%). Hemodynamic parameters remained stable throughout the intervention, and no adverse events or exercise intolerance were observed.
Conclusion: Phase II cardiac rehabilitation using treadmill and cycle ergometer exercise was safe and effective in improving aerobic capacity and functional tolerance in a patient with CHF after CABG.

Downloads

Published

2026-01-03